Standardized Rehabilitation and Hospital Length of Stay Among Patients With Acute Respiratory Failure

The researchers compared two approaches to rehabilitation for patients who were in the intensive care unit (ICU) because their lungs had failed and they needed a breathing machine (mechanical ventilation).

**Intervention (Standardized Rehabilitation Therapy, SRT):** A daily, protocol-driven program delivered seven days per week until hospital discharge. It included three components:

1. **Passive range of motion:** A therapist moved the patient's joints (shoulders, elbows, wrists, hips, knees, ankles) through their full range of motion while the patient was too weak or sedated to move themselves. This was done to prevent joint stiffness and muscle shortening.

2. **Physical therapy:** Once the patient was awake enough, they worked on sitting up, standing, walking, and basic mobility tasks.

3. **Progressive resistance exercise:** Using ankle weights, resistance bands, or small hand weights, patients did exercises like leg presses, knee extensions, and bicep curls. The resistance was increased over time as the patient got stronger.

**Comparator (Usual Care):** Patients received physical therapy only if the clinical team (doctors or nurses) ordered it, and only on weekdays (Monday through Friday). There was no standard protocol — the type, frequency, and intensity of therapy varied based on individual clinician judgment.

**Primary Outcome:** Hospital length of stay (LOS) — the number of days from admission to discharge from the hospital.

**Secondary Outcomes:** Days on the ventilator, days in the ICU, physical function (measured by the Short Physical Performance Battery, or SPPB), self-reported physical and mental health (SF-36 questionnaire), ability to perform daily activities (Functional Performance Inventory, or FPI), cognitive function (Mini-Mental State Examination, or MMSE), and muscle strength (handgrip dynamometer and handheld dynamometer).

**Sample size:** 300 patients (150 in the SRT group, 150 in the usual care group).

**Population:** Adults admitted to the ICU at Wake Forest Baptist Medical Center in North Carolina with acute respiratory failure requiring mechanical ventilation.

**Mean age:** 58 years.

**Sex:** 55% women.

**Key inclusion criteria:** On mechanical ventilation for less than 7 days before enrollment; expected to need ventilation for at least 48 more hours; able to follow simple commands (e.g., "squeeze my hand") once sedation was reduced.

**Key exclusion criteria:** Preexisting neuromuscular disease (e.g., ALS, muscular dystrophy), severe brain injury, spinal cord injury, or a do-not-resuscitate order at the time of screening.

**Setting:** Single academic medical center in the United States.

**Hospital length of stay:** Calculated from the date of hospital admission to the date of discharge (or death, if the patient died in hospital). This was extracted from the electronic medical record.

**Ventilator days:** Number of days the patient required mechanical ventilation, recorded from the medical record.

**ICU days:** Number of days the patient spent in the ICU, recorded from the medical record.

**Short Physical Performance Battery (SPPB):** A performance-based test of lower extremity function. It includes three components: (1) standing balance (side-by-side, semi-tandem, and tandem stands for up to 10 seconds each), (2) gait speed over a 4-meter walk, and (3) time to rise from a chair five times without using arms. Each component is scored 0–4, for a total score of 0–12 (higher = better function). A score of 0 means the patient could not attempt the test; 12 means high function.

**36-Item Short-Form Health Survey (SF-36):** A self-reported questionnaire measuring eight domains of health, including physical functioning, role limitations due to physical health, bodily pain, general health, vitality, social functioning, role limitations due to emotional problems, and mental health. Two summary scores are calculated: Physical Component Summary (PCS) and Mental Component Summary (MCS), each normed to a mean of 50 in the general US population (higher = better health).

**Functional Performance Inventory (FPI):** A self-reported questionnaire measuring how much difficulty a person has performing daily activities (e.g., bathing, dressing, cooking, walking outdoors). Scores range from 0 to 3 (higher = less difficulty, better function).

**Mini-Mental State Examination (MMSE):** A 30-point cognitive screening test covering orientation, attention, memory, language, and visuospatial skills. Scores below 24 suggest cognitive impairment.

**Handgrip strength:** Measured using a handheld dynamometer (a device the patient squeezes). Reported in kilograms. Higher = stronger.

**Handheld dynamometer strength:** Measured using a handheld dynamometer for specific muscle groups (e.g., shoulder abductors, knee extensors). Reported in pounds. Higher = stronger.

**Study design:** Single-center, parallel-group, randomized clinical trial (RCT).

**Randomisation:** Patients were randomly assigned (1:1 ratio) to SRT or usual care using a computer-generated randomisation sequence. The allocation was concealed — meaning the researchers enrolling patients did not know which group the next patient would be assigned to. This prevents selection bias (e.g., unconsciously enrolling sicker patients into one group).

**Blinding:** This was an **assessor-blinded** trial. The patients and the therapists delivering the intervention obviously knew which group they were in (you cannot blind a patient to whether they are receiving daily therapy or not). However, the researchers who performed the outcome assessments (e.g., the SPPB test, handgrip strength, questionnaires) were blinded to group assignment. This is critical because it prevents the assessor's expectations from influencing the results (e.g., unconsciously encouraging a patient in the SRT group to try harder). The statisticians were also blinded to group assignment until after the primary analysis was complete.

**Duration:**

The intervention was delivered daily from enrollment until hospital discharge. The median duration of therapy delivery was 8 days for passive range of motion, 5 days for physical therapy, and 3 days for progressive resistance exercise in the SRT group.

Follow-up assessments occurred at ICU discharge, hospital discharge, and at 2, 4, and 6 months after hospital discharge.

**Statistical approach:** The primary analysis was intention-to-treat — meaning all patients were analysed in the group they were randomised to, regardless of whether they actually received the therapy. This preserves the benefits of randomisation and gives a real-world estimate of the intervention's effect (since some patients will inevitably not complete the full protocol). The primary outcome (hospital LOS) was compared using the Wilcoxon rank-sum test (a non-parametric test appropriate for skewed data like length of stay). Results are reported as medians with interquartile ranges (IQR) and median differences with 95% confidence intervals.

**What this design can and cannot prove:**

**Can prove:** Because of randomisation and assessor blinding, this design can establish that the SRT program did not cause a reduction in hospital LOS compared to usual care in this specific population. The randomisation balances known and unknown confounders between groups, so any difference in LOS can be attributed to the intervention (or lack thereof).

**Cannot prove:** This was a single-center study, so the results may not generalise to other hospitals with different patient populations, staffing levels, or usual care practices. The study cannot tell us whether a different type of rehabilitation (e.g., higher intensity, longer duration, or starting earlier) would be effective. It also cannot tell us about long-term outcomes beyond 6 months. Because the intervention was a bundle of three components (passive range of motion, physical therapy, and resistance exercise), the study cannot isolate which component (if any) was responsible for the observed improvements in physical function.

**Major methodological weaknesses:**

**Single center:** Results may not be generalisable.

**No blinding of patients or therapists:** This is unavoidable in a rehabilitation trial, but it means that placebo effects or differential expectations could influence some outcomes (especially self-reported measures like the SF-36 and FPI).

**Low adherence to the intervention:** In the SRT group, the median number of days of physical therapy was only 5 (out of a median hospital stay of 10 days), and progressive resistance exercise was delivered on only 3 days. This means many patients did not receive the full intended dose of therapy, which could dilute the treatment effect.

**Usual care group received some therapy:** The usual care group received a median of 1 day of physical therapy (IQR 0–8), meaning some patients in the control group actually got quite a bit of therapy. This reduces the contrast between groups and makes it harder to detect a difference.

**Primary outcome — Hospital length of stay:**

- SRT group: median 10 days (IQR 6–17)

- Usual care group: median 10 days (IQR 7–16)

- Median difference: 0 days (95% CI, -1.5 to 3 days; P = .41)

- **No statistically significant difference.**

**Secondary outcomes — Ventilator and ICU days:**

- No significant difference in duration of mechanical ventilation or ICU length of stay (exact numbers not reported in the abstract, but stated as "no difference").

**Secondary outcomes — Physical function at 6 months:**

- **Short Physical Performance Battery (SPPB):** SRT group scored 1.1 points higher than usual care (95% CI, 0.04 to 2.1; P = .04). This is a statistically significant but modest improvement.

- **SF-36 Physical Function Scale:** SRT group scored 12.2 points higher (95% CI, 3.8 to 20.7; P = .001). This is a large and clinically meaningful difference (the scale ranges from 0 to 100, with a 10-point difference often considered noticeable to patients).

- **Functional Performance Inventory (FPI):** SRT group scored 0.2 points higher (95% CI, 0.04 to 0.4; P = .02). This is a small but statistically significant difference.

**Secondary outcomes — No significant difference at 6 months:**

- Handgrip strength: difference of 2.0 kg (95% CI, -1.3 to 5.4; P = .23)

- Handheld dynamometer strength: difference of 0.4 lb (95% CI, -2.9 to 3.7; P = .82)

- SF-36 Physical Component Summary: difference of 3.4 points (95% CI, -0.02 to 7.0; P = .05) — borderline significant, but the confidence interval includes zero.

- SF-36 Mental Component Summary: difference of 2.4 points (95% CI, -1.2 to 6.0; P = .19)

- Mini-Mental State Examination (MMSE): difference of 0.6 points (95% CI, -0.2 to 1.4; P = .17)

**Hospital length of stay:** The intervention had zero effect — the median stay was exactly 10 days in both groups. The confidence interval (-1.5 to 3 days) tells us that the true effect is unlikely to be larger than 3 days shorter or 1.5 days longer. For a patient facing a 10-day hospital stay, this is a negligible difference.

**Physical function (SPPB):** The 1.1-point improvement on a 12-point scale is modest. To put it in context, a 1-point change on the SPPB is roughly equivalent to being able to stand on one leg for 3 seconds longer or walking 4 meters about 0.5 seconds faster. This is noticeable but not transformative.

**Self-reported physical function (SF-36 Physical Function Scale):** The 12.2-point improvement is substantial. On a 0–100 scale, this is roughly the difference between "limited a lot" and "limited a little" in activities like climbing stairs, walking several blocks, or carrying groceries. This is the kind of improvement that would meaningfully affect a person's daily life.

**Functional Performance Inventory:** The 0.2-point improvement on a 0–3 scale is small. It might mean the difference between "some difficulty" and "a little difficulty" with one or two daily activities.

**Single-center design:** Results may not apply to other hospitals with different patient demographics, staffing ratios, or rehabilitation protocols.

**Low adherence to the intervention:** The median number of days of physical therapy in the SRT group was only 5, and resistance exercise was delivered on only 3 days. This is far from the "daily" therapy intended. Reasons included patient refusal, medical instability, or scheduling conflicts. This reduces the "dose" of the intervention and may explain why the primary outcome was negative.

**Contamination of the control group:** The usual care group received a median of 1 day of physical therapy, but the interquartile range was 0 to 8 days, meaning some patients in the control group received substantial therapy. This blurs the distinction between groups.

**No blinding of patients or therapists:** Patients knew whether they were getting daily therapy or not, which could influence self-reported outcomes (e.g., SF-36, FPI) through expectation or placebo effects. The objective measures (SPPB, handgrip strength) are less susceptible to this bias.

**Multiple comparisons:** The study tested many secondary outcomes without adjusting for multiple comparisons. Some of the "significant" findings (e.g., SPPB at P = .04) could be due to chance. The authors do not appear to have applied a correction like Bonferroni.

**Loss to follow-up:** At 6 months, some patients were lost to follow-up or died. The authors do not report exact attrition rates in the abstract, but this is a common issue in ICU trials and can bias results if the dropouts differ between groups.

**Industry funding:** The study was funded by the National Institutes of Health (NIH), so no industry bias is apparent.

For someone running their own n=1 experiment (e.g., recovering from a serious illness or surgery that required bed rest):

### What to test

**Intervention:** A structured daily rehabilitation program combining passive stretching (if you cannot move yourself), active mobility exercises (sitting, standing, walking), and progressive resistance training (using body weight, resistance bands, or light weights). The key is **daily** delivery and **progression** (increasing the resistance or repetitions over time).

**Dose:** Aim for at least 15–30 minutes of active exercise per day, plus 5–10 minutes of stretching. The study suggests that even a modest dose (median 5 days of PT over a 10-day stay) produced benefits in physical function.

### Minimum meaningful duration

**For acute recovery:** At least 7–10 days of daily rehabilitation to see improvements in physical function. The study's benefits were seen at 6 months, but the intervention was delivered during the hospital stay (median 10 days).

**For your own experiment:** Run the intervention for at least 2 weeks to see if you notice changes in mobility, strength, or daily function. Longer is better (4–6 weeks).

### What to measure (specific metrics)

**Primary metric:** A performance-based test of physical function, like the **Short Physical Performance Battery (SPPB)** . You can do this at home: time yourself walking 4 meters (about 13 feet) at your usual pace, time yourself standing from a chair five times without using your arms, and test your balance (side-by-side, semi-tandem, and tandem stands for 10 seconds each). Score yourself 0–4 on each component (see online scoring guides).

**Secondary metrics:**

- **Self-reported physical function